Additionally, MYCN-A tumors exhibited the downregulation of immune-activating genes such as CD48 and CD86, and a slight decrease in CD40 expression, potentially contributing to an immunosuppressive tumor microenvironment. This evidence concerns the gene CD48 and neoplasm.